MIMS Research Foundation is developing a novel drug to treat coronavirus
The company have repurposed its sepsis research for COVID management
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Systemic Inflammatory Response Syndrome
Biocon expands its strategic partnership with CytoSorbents
Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the ICU as…